Stock 7V91 VISIOMED GROUP SA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Visiomed Group SA Deutsche Boerse AG

Equities

7V91

FR0013481835

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG
Other stock markets
 20:41:18 26/04/2024 BST 		5-day change 1st Jan Change
0.18 EUR +3.45% Intraday chart for Visiomed Group SA +0.22% -30.23%
03-26 Visiomed: share price rises on 'record' 2023 results CF
02-13 Visiomed: 38% increase in annual sales CF

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 28.94 6.061 12.87 22.43 11.49 98.55
Enterprise Value (EV) 1 25.54 8.198 9.018 21.66 9.877 101.8
P/E ratio -1.46 x -0.18 x -0.39 x -3.19 x -1.33 x -22.7 x
Yield - - - - - -
Capitalization / Revenue 2.77 x 0.69 x 1.26 x 1.18 x 1.6 x 6.82 x
EV / Revenue 2.44 x 0.94 x 0.88 x 1.14 x 1.38 x 7.05 x
EV / EBITDA -1.95 x -0.47 x -0.5 x -3.49 x -3.43 x -68.6 x
EV / FCF -2.06 x -1.43 x -1.24 x -2.45 x 3.8 x -6.37 x
FCF Yield -48.4% -69.7% -81% -40.8% 26.3% -15.7%
Price to Book 2.28 x 16.7 x -2.52 x -5.08 x 0.92 x 4.94 x
Nbr of stocks (in thousands) 709 1,774 14,359 25,400 121,996 241,834
Reference price 2 40.80 3.416 0.8960 0.8830 0.0942 0.4075
Announcement Date 30/04/18 30/04/19 31/03/20 31/03/21 01/04/22 26/04/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 10.47 8.746 10.24 19.02 7.179 14.44
EBITDA 1 -13.09 -17.45 -18.1 -6.199 -2.876 -1.484
EBIT 1 -13.72 -18.16 -18.88 -6.581 -3.677 -4.082
Operating Margin -131.14% -207.63% -184.38% -34.59% -51.22% -28.26%
Earnings before Tax (EBT) 1 -13.66 -20.13 -24.24 -5.314 -4.315 -5.164
Net income 1 -13.15 -19.79 -24.38 -5.15 -4.457 -5.277
Net margin -125.69% -226.24% -238.11% -27.07% -62.08% -36.53%
EPS 2 -28.00 -18.83 -2.318 -0.2766 -0.0706 -0.0179
Free Cash Flow 1 -12.37 -5.713 -7.302 -8.843 2.598 -15.99
FCF margin -118.23% -65.32% -71.32% -46.48% 36.19% -110.71%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 30/04/18 30/04/19 31/03/20 31/03/21 01/04/22 26/04/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 2.14 - - - 3.26
Net Cash position 1 3.4 - 3.85 0.77 1.62 -
Leverage (Debt/EBITDA) - -0.1225 x - - - -2.194 x
Free Cash Flow 1 -12.4 -5.71 -7.3 -8.84 2.6 -16
ROE (net income / shareholders' equity) -126% -304% 1,026% 108% -92.2% -27.5%
ROA (Net income/ Total Assets) -43.4% -58.7% -70.9% -39.9% -9.2% -6.37%
Assets 1 30.32 33.7 34.36 12.92 48.46 82.9
Book Value Per Share 2 17.90 0.2000 -0.3600 -0.1700 0.1000 0.0800
Cash Flow per Share 2 4.180 0.1200 0.4500 0.0300 0.0500 0.0100
Capex 1 0.67 0.76 0.06 0.25 0.2 5.52
Capex / Sales 6.42% 8.71% 0.55% 1.29% 2.73% 38.18%
Announcement Date 30/04/18 30/04/19 31/03/20 31/03/21 01/04/22 26/04/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ALVMG Stock
  4. 7V91 Stock
  5. Financials Visiomed Group SA